The results showed that the activity of AKT was positively correlated with the level of p-GSK-3α and that the activity of AKT in A549 and A549/DDP lung cancer cells was significantly reduced when the cells received both treatment schemes. This evidence concerns the gene AKT1 and lung carcinoma.